Pay in 4 interest-free payments of $7.40 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
NMNAT2 is a druggable target to drive neuronal NAD production [PMID: 39048544] Laboratory literature summary: NMNAT2 is a druggable target to drive neuronal NAD production
10.1161/01.RES.0000258171.08020.72 Circ Res
A WHO consultation identified the most vulnerable groups as elderly individuals, infants, preschool-aged children, and pregnant or lactating women, due to either increased nutritional demands or impaired absorption capacity ( Addressing the prevention of B12 deficiency and its public health implications requires a comprehensive, life-course approach based on integrated strategies targeting early detection, dietary optimisation, and effective supplementation, in order to mitigate the long-term consequences of inadequate cobalamin status ( Intramuscular (IM) injection is the most invasive and costly administration method, requiring trained personnel and clinical visits
It stabilizes the fracture fragments and provides a framework that will eventually be replaced by actual bone
US$ 28.77
US$ 26.02
US$ 23.38
US$ 24.21
US$ 22.04
US$ 29.46
US$ 23.65
US$ 25.46
US$ 26.54
